Here's How Much $100 Invested In Halozyme Therapeutics 15 Years Ago Would Be Worth Today

benzinga.com/insights/news/25/06/45917203/heres-how-much-100-invested-in-halozyme-therapeutics-15-years-ago-would-be-worth-today

Halozyme Therapeutics (NASDAQ:HALO) has outperformed the market over the past 15 years by 2.54% on an annualized basis producing an average annual return of 14.44%. Currently, Halozyme Therapeutics has a market capitalization of $6.72 billion.
Buying $100 In HALO: If ...
Full story…

This story appeared on benzinga.com, 2025-06-12 22:45:16.
The Entire Business World on a Single Page. Free to Use →